Biotechnology Industry Overview
The Biotechnology industry, part of the Healthcare sector, includes 646 publicly traded companies with a combined market capitalization of $1.18T. The industry is led by Vertex Pharmaceuticals Incorporated (VRTX), Regeneron Pharmaceuticals, Inc. (REGN), argenx SE (ARGX).
Among the 646 listed Biotechnology companies, market capitalizations range from $110.64B (Vertex Pharmaceuticals Incorporated) down to $32.93B (Revolution Medicines, Inc.), highlighting the wide size disparity across the industry. The average market cap across the industry is $1.82B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Biotechnology Industry Valuation
The Biotechnology industry currently trades at an average price-to-earnings (P/E) ratio of 53.8. This elevated multiple indicates that investors are pricing in strong future earnings growth across Biotechnology companies. Note that some companies in the industry report no P/E ratio, typically because they are currently unprofitable or in early growth stages.
Biotechnology Dividend Profile
7 out of 646 Biotechnology companies (1%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Biotechnology stocks is 10.86%. Most Biotechnology companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Largest Biotechnology Companies by Market Cap
| Company | Ticker | Market Cap | P/E Ratio |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | VRTX | $110.64B | 25.8 |
| Regeneron Pharmaceuticals, Inc. | REGN | $66.98B | 15.6 |
| argenx SE | ARGX | $50.52B | 36.0 |
| Alnylam Pharmaceuticals, Inc. | ALNY | $39.45B | 74.1 |
| Revolution Medicines, Inc. | RVMD | $32.93B | N/A |
The table above shows the top 5 Biotechnology companies ranked by market capitalization. P/E ratios reflect trailing twelve months earnings where available.
Frequently Asked Questions
What is the largest Biotechnology company? The largest Biotechnology company by market capitalization is Vertex Pharmaceuticals Incorporated (VRTX), valued at $110.64B. Use the full listing below to explore all Biotechnology companies and compare their financials.
How many Biotechnology stocks are there? There are 646 publicly traded Biotechnology companies listed on major US exchanges, ranging from Vertex Pharmaceuticals Incorporated (VRTX) to Revolution Medicines, Inc. (RVMD) by market capitalization. This directory spans 13 pages, with all companies sorted by market cap for easy comparison.
How many Biotechnology stocks pay dividends? 7 of the 646 Biotechnology companies (1%) currently distribute dividends. The average yield among payers is 10.86%. Dividend policies vary significantly across Biotechnology companies — browse individual stock pages for the latest yield and payout details.
What is the average P/E ratio for Biotechnology stocks? The average trailing P/E ratio for the Biotechnology industry is 53.8x. Individual company valuations can vary widely — click through to any stock page for detailed valuation metrics.
Explore Biotechnology Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 646 Biotechnology companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Biotechnology stocks head to head. All data is updated regularly to reflect the latest available financials.